On d 21, DM, OM, CP, and CF utilization increased significantly (P < 0.01) in the MMS, MMB, MFS, MFB, MFM, and MBP groups compared with that in the CON and ENR groups, whereas the treatments had no effect on Ca (P = 0.11) and P (P = 0.1) utilization (Table 3). The gene discussed is CFTR; the disease is ocular melanoma.